Transient Receptor Potential Channels Contribute to Pathological Structural and Functional Remodeling After Myocardial InfarctionNovelty and Significance
Jump to

Abstract
Rationale: The cellular and molecular basis for post–myocardial infarction (MI) structural and functional remodeling is not well understood.
Objective: Our aim was to determine if Ca2+ influx through transient receptor potential canonical (TRPC) channels contributes to post-MI structural and functional remodeling.
Methods and Results: TRPC1/3/4/6 channel mRNA increased after MI in mice and was associated with TRPC-mediated Ca2+ entry. Cardiac myocyte–specific expression of a dominant-negative (loss-of-function) TRPC4 channel increased basal myocyte contractility and reduced hypertrophy and cardiac structural and functional remodeling after MI while increasing survival in mice. We used adenovirus-mediated expression of TRPC3/4/6 channels in cultured adult feline myocytes to define mechanistic aspects of these TRPC-related effects. TRPC3/4/6 overexpression in adult feline myocytes induced calcineurin (Cn)-nuclear factor of activated T-cells (NFAT)–mediated hypertrophic signaling, which was reliant on caveolae targeting of TRPCs. TRPC3/4/6 expression in adult feline myocytes increased rested state contractions and increased spontaneous sarcoplasmic reticulum Ca2+ sparks mediated by enhanced phosphorylation of the ryanodine receptor. TRPC3/4/6 expression was associated with reduced contractility and response to catecholamines during steady-state pacing, likely because of enhanced sarcoplasmic reticulum Ca2+ leak.
Conclusions: Ca2+ influx through TRPC channels expressed after MI activates pathological cardiac hypertrophy and reduces contractility reserve. Blocking post-MI TRPC activity improved post-MI cardiac structure and function.
Introduction
Cardiac systolic stress is increased in cardiovascular diseases such as hypertension and myocardial infarction (MI), and this requires an increase in contractile Ca2+. Persistent pathological stress usually results in a Ca2+-dependent pathological hypertrophy with Ca2+-related contractility defects. Abnormal contractile Ca2+ with depressed contractility reserve is a hallmark of cardiac hypertrophy and heart failure,1 but this contractile Ca2+ does not seem to be the source for activation of the signaling pathways that cause pathological hypertrophy. Recent data suggest that separate pools of myocyte signaling and contractile Ca2+ are involved in the induction of hypertrophy.2 The source and cellular location of the signaling Ca2+ is still not clearly defined. The present study explores the hypothesis that the expression of transient receptor potential canonical (TRPC) channels are induced after MI, and Ca2+ influx through these channels within specific microdomains is necessary for the development of pathological hypertrophy, as well as for affecting contractility reserve that ultimately contributes to impaired pump function of the diseased heart.3,4
The function of the TRP family of channels is not well understood in the heart, but it has been implicated in contributing to the initiation of pathological cardiac remodeling.5–8 TRP channels are a class of nonselective cation influx channels that are grouped into 7 families6,9 and are present in many different cell types.10 The TRPC family includes 7 isoforms (TRPC1–7) that have been divided into 2 general subfamilies based on structural and functional similarities: TRPC1/4/5 and TRPC3/6/7.6 In general, TRPC3/6/7 are activated by diacylglycerol generated by G protein–coupled receptors/Gαq/phospholipase C signaling,11 whereas TRPC1/4/5 can be activated by stretch or depletion of intracellular Ca2+ stores (store-operated Ca2+ entry; SOCE)12,13; however, TRPC6 has also been implicated as a mechanosensing isoform as well.14 Functional TRPC channels are formed as tetramers of individual 6-transmembrane spanning subunits. Interestingly, the channels can be homomeric or heteromeric assemblies with oligomerization occurring within and between subfamilies or beyond the TRPC family altogether (ie, TRPCs can oligomerize with TRPVs [transient receptor potential vanilloid] and TRPMs [transient receptor potential melastatin]).15–18
TRPC channels are expressed at very low levels in normal adult cardiac myocytes, but expression and activity of select isoforms seem to be increased in pathological hypertrophy and heart failure.5,7,8,19 TRPC channels have been suggested as initiators of Ca2+-dependent signaling that leads to pathological cardiac remodeling, hypertrophy, and failure.5,6 Transgenic cardiac-specific overexpression of TRPC3 or TRPC6 channels in mice causes re-expression of fetal genes, myocyte hypertrophy, and activation of apoptotic signaling.7,20,21 The prohypertrophic effects of TRPC channels have also been shown in vitro in cultured cardiomyocytes.5,22 Studies involving loss of TRPC function suggest a necessary role for these channels in pathological hypertrophy. TRPC3 inhibition with the inhibitor Pyr3 blocks cardiac hypertrophy in mice subjected to pressure overload,23 and this finding has been supported by data in gene-deleted mice (TRPC18 and TRPC3/624) and in mice expressing dominant-negative (dn) mutants of select channels (dnTRPC3,4,6).21 Interestingly, mice expressing dnTRPC4 also inhibited the activity of the TRPC3/6/7 subfamily in the heart, which suggests that TRPC1/4/5 and 3/6/7 subfamilies function in coordinated complexes, at least when overexpressed.21 The present study takes advantage of the dnTRPC strategy to define the role of TRPCs in post-MI structural and functional remodeling.
Ca2+ influx through TRPC channels was shown to activate the Ca2+-sensitive phosphatase calcineurin that initiates diverse intracellular responses through its downstream transcriptional effector, nuclear factor of activated T cells (NFAT).12,13,15,22 Calcineurin-NFAT (Cn-NFAT) signaling in the heart is a well-known prohypertrophic pathway that is both necessary and sufficient for pathological growth.3 Activation of this signaling cascade is thought to be the primary mechanism through which TRPC channels regulate cardiac hypertrophy. A recent in vitro study from our group suggests that TRPCs and l-type Ca2+ channels (LTCC) work in a coordinated fashion to activate Cn-NFAT signaling.22 Additional studies from our group showed that a subpopulation of LTCC localized specifically to caveolae membrane signaling microdomains is involved in pathological hypertrophic signaling.25 The present study explores the hypothesis that TRPCs and LTCC function as essential partners in these caveolae signaling microdomains where their activity initiates hypertrophic Cn-NFAT signaling after MI.
The role of TRPC channels within excitation–contraction coupling microdomains has not been clearly defined. There are data in mice associating increased TRPC activity with reduced contractility7,20 and loss of TRPC function with increased contractility,21 but the mechanisms underlying these effects are not understood. The present study explores the hypothesis that Ca2+ influx through TRPC channels within excitation–contraction coupling microdomains results in reduced contractility reserve after MI.
Methods
See the extended Materials and Methods section in the Online Data Supplement. In brief, adult mouse and feline myocytes were isolated.26–29 TRPC-mediated Ca2+ entry20 and Ca2+ spark activity were measured in unpaced myocytes loaded with Fluo-4, whereas pacing protocols were implemented for fractional shortening and Ca2+ transient contractility studies.26–29 NFAT translocation studies were performed in adult feline myocytes (AFMs) using adenoviral-mediated expression of NFAT-GFP,22,25 and immunoprecipitation, sucrose density gradients, and Western blot analysis were used for membrane localization25 and phosphorylation30 studies. Animal procedures were approved by the Temple University Institutional Animal Care and Use Committee. We induced MI in mice by permanent occlusion of the left main coronary artery as previously described,31 and animals were monitored during the course of the study using in vivo echocardiography.30
Results
TRPC Channel Expression and Activity Is Induced After MI
Individual TRPC channels are expressed at low levels in normal adult heart, but expression and activity of select isoforms are upregulated in pathological stress conditions.3,6–8,19 We induced MI in mice as previously described31 and measured the abundance of individual TRPC channel mRNA by reverse transcriptase polymerase chain reaction. MI resulted in the significant induction of hypertrophic gene markers and TRPC1/3/4/6 isoforms in mice 1, 2, and 6 weeks post-MI compared with sham animals (Figure 1A).
Myocardial infarction induces transient receptor potential canonical (TRPC) channel expression and activity in mice, and overexpression of TRPC channels in feline myocytes leads to increased membrane Ca2+ influx. A, Reverse transcriptase polymerase chain reaction shows an upregulation of TRPC1/3/4/6 channel isoforms at 1, 2, and 6 wks post-myocardial infarction (MI) along with the activation of the fetal gene program. B to D, TRPC-mediated Ca2+ entry in isolated myocytes from sham mice (left) or 1 wk (B), 2 wk (C), or 6 wk (D) post-MI mice (right) in the presence of the TRPC channel agonist OAG (10 umol/L) and the sarcoplasmic reticulum Ca2+ ATPase inhibitor cyclopiazonic acid (CPA; 5 umol/L). Where indicated, the TRPC antagonists SKF-96365 (5 umol/L), GSK503A (GSK; 10 umol/L), Pyr10 (3 umol/L), or the l-type Ca2+ channel inhibitor nifedipine (Nif; 10 umol/L) were used. E, Adult feline myocytes infected with the indicated adenoviruses and assayed for TRPC-mediated Ca2+ entry. P<0.05 was considered significant (ns, P>0.05, *P≤0.05, **P≤0.01, ***P≤0.001 vs sham). ANF indicates atrial natriuretic factor; BNP, brain natriuretic peptide; MHC, myosin heavy chain; and SMA, skeletal muscle actin.
TRPC-mediated Ca2+ influx was determined using a TRPC-mediated Ca2+ entry bioassay. In most cell types, the depletion of intracellular Ca2+ stores leads to the activation of SOCE through defined channel complexes that include STIM (stromal interaction molecule) and Orai and potentially TRPC channels on the plasma membrane.32 Although the role of TRPC channels in SOCE in cardiac myocytes is not well defined, sarcoplasmic reticulum (SR) Ca2+ depletion of isolated myocytes followed by the reintroduction of Ca2+ in the presence of TRPC channel activator 1-oleoyl-2-acetyl-sn-glycerol (OAG), a stable cell-permeable analog to the known TRPC agonist diacylglycerol, is an approach that has been used to assess TRPC-mediated Ca2+ entry.6,20 Myocytes isolated from mice 1, 2, or 6 weeks post-MI showed substantial TRPC-mediated Ca2+ entry, whereas myocytes from sham animals showed no detectable activity (Figure 1B–1D). Similar results were seen in these MI myocytes in response to angiotensin II (Online Figure IA). The specificity of TRPC-mediated Ca2+ entry in MI myocytes was validated by inhibition with the pan TRPC antagonist SKF-96365 or the TRPC3/6-specific inhibitor GSK503A24 (Figure 1B–1D). TRPC-mediated Ca2+ entry was not inhibited by the LTCC antagonist nifedipine, documenting that this Ca2+ entry is independent of LTCC-mediated Ca2+ entry. Controls were also performed in cells incubated with cyclopiazonic acid alone, which resulted in a transient Ca2+ entry in 6-week MI myocytes but no detectable entry in sham myocytes (Online Figure IB) and also with myocytes treated with OAG alone (Online Figure IC), which resulted in Ca2+ entry in MI myocytes only and led to spontaneous contractions.
AFMs Expressing TRPC Channels Have Increased Membrane Ca2+ Influx
To further characterize the properties of TRPC channels in adult cardiac myocytes, we used cultured isolated AFMs because their electrophysiological and Ca2+ regulatory properties more closely resemble those of human myocytes (in comparison to rodent myocytes).33 AFMs survive in culture without the use of drugs that reduce Ca2+ influence and overload. This allows for manipulation of protein expression using adenoviral vectors in an adult myocyte that maintains stable electric and mechanical properties.27,34–36
We performed TRPC-mediated Ca2+ entry measurements in AFMs infected with adenovirus (Ad) for red fluorescent protein (RFP; control), TRPC3, TRPC4, TRPC6, or a dnTRPC4 or dnTRPC6. Because of their ability to hetero-oligomerize, the use of a dnTRPC4/6 effectively inhibits the activity of all TRPC subfamilies of channels6,21 (Online Figure II). Ad-RFP–infected myocytes showed little or no TRPC-mediated Ca2+ entry, whereas myocytes infected with Ad-TRPC3, TRPC4, or TRPC6 showed significant Ca2+ entry, which was inhibited by the expression of Ad-dnTRPC4 or dnTRPC6 but unaffected by nifedipine (Figure 1E). TRPC-mediated Ca2+ entry was inhibited by the pan TRPC antagonist SKF-96365 in TRPC3/4/6-infected cells, whereas the more targeted TRPC3/6 inhibitor GSK503A only inhibited TRPC-mediated Ca2+ entry in TRPC3/6-infected cells. Similarly, the TRPC3 inhibitor Pyr1037 was able to inhibit TRPC-mediated Ca2+ entry in TRPC3-infected cells. Controls were also performed in cells incubated with cyclopiazonic acid alone, which resulted in a transient Ca2+ entry in TRPC4-infected myocytes only but no detectable entry in control or TRPC3/6 expressing myocytes (Online Figure ID). This is likely because of the ability of TRPC4 to participate in SOCE, whereas TRPC3/6 tends to be more agonist-induced channels. Similar to our findings in mouse myocytes, TRPC-infected AFMs treated with OAG alone (Online Figure IE) resulted in Ca2+ entry and led to spontaneous contractions.
TRPC Channel Overexpression in AFMs Enhances SR Ca2+ in AFMs
TRPC3/6 overexpression in the adult mouse heart is linked to cardiac hypertrophy and depressed cardiac contractility.7,20 Myocyte contractions (fractional shortening) and Ca2+ transients were measured in AFMs infected with Ad-RFP, -TRPC3, -TRPC4, -TRPC6 or -dnTRPC4 or -dnTRPC6 after periods of rest (Figure 2A–2C). One of the hallmark contractile characteristics of large mammalian myocytes, including AFMs, is a positive contractile staircase when stimulation is reinstated after a period of rest.26,38 AFMs, as well as those of other large mammals including humans, have a lower cytoplasmic [Na+] than found in rodents.34 This promotes forward-mode Na+/Ca2+ exchange (NCX), which in the absence of pacing results in low cytoplasmic [Ca]2+ and very small amounts of Ca2+ stored in the SR. Therefore, in normal AFMs, the first post-rest contraction and Ca2+ transient are small and then increase in subsequent beats as the SR is progressively loaded with Ca2+ to a new steady state. After rest periods, control (Ad-RFP) AFMs showed a beat-dependent increase in their contractions and Ca2+ transients (Figure 2A). Conversely, the first post-rest beat in Ad-TRPC3, -TRPC4, or -TRPC6–infected cells was larger and similar to the steady-state contraction. Intracellular Ca2+ was elevated in Ad-TRPC3, -TRPC4, and -TRPC6–infected cells compared with Ad-RFP cells as evidenced by increased fractional shortening (Figure 2A and 2B) and increased Ca2+ transient amplitude (F/F0; Figure 2A and 2C) in the first paced contraction after a nonpaced interval. These TRPC-mediated effects on rested state contractions and Ca2+ transients were inhibited by coexpression with dnTRPC4 or dnTRPC6 (Figure 2; Online Figure III). These results suggest that Ca2+ influx through TRPC channels maintains SR Ca2+ stores in the absence of LTCC-mediated Ca2+ entry, supporting a role for TRPC-mediated Ca2+ entry in disease when the normal pathway for Ca2+ influx (through LTCC) is reduced and the SR Ca2+ load is diminished, although the nondiseased adult heart probably does not use this pathway because TRPC channels are not appreciably expressed.
Transient receptor potential canonical channel overexpression in adult feline myocytes (AFMs) enhances sarcoplasmic reticulum Ca2+ during resting conditions. A, Representative fractional shortening and Ca2+ transient traces from AFMs infected with the indicated adenoviruses and stimulated to pace after a period of rest. Fractional shortening (B) and peak Ca2+ transients (C) are represented as the average raw values of the initial beat (left) and as the ratio of the steady-state raw values divided by the initial beat raw value (right). P<0.05 was considered significant (ns, P>0.05, *P≤0.05 vs red fluorescent protein (RFP) control; #P≤0.05 vs raw value of first beat of the same experimental group). All statistical analysis was done on raw values.
Ca2+ Influx Through TRPC Channels Induces Ca2+ Spark Activity in AFMs
TRPC3/4/6 expressing AFMs had enhanced Ca2+ influx at rest that promotes SR Ca2+ loading, but steady-state contractions were not increased. Therefore, we tested the idea that persistent Ca2+ influx through TRPC can lead to excess spontaneous SR Ca2+ release (SR Ca2+ leak). Spontaneous Ca2+ sparks were measured to address this idea.39 Ca2+ sparks are local spontaneous Ca2+ release events caused by the opening of a cluster of ryanodine receptor (RyR) channels in the absence of LTCC opening.40,41 These events are common in quiescent rodent myocytes because of their high [Na+] that promotes Ca2+ entry via reverse-mode NCX activity culminating in SR Ca2+ overload.34,42 As discussed above, AFMs maintain low [Na]2+, and they do not exhibit Ca2+ accumulation or spontaneous SR Ca2+ release in long-term culture.34 We infected AFMs with Ad-RFP (control), -TRPC3, -TRPC6, -TRPC3 and -dnTRPC6, or -TRPC6 and dnTRPC4 and measured Ca2+ spark activity in the presence and absence of the TRPC channel agonist OAG. Control myocytes rarely exhibited Ca2+ sparks but did show a low level of Ca2+ spark activity with the addition of OAG (Figure 3A and 3B). AFMs infected with TRPC3 or TRPC6 showed robust Ca2+ spark activity under baseline conditions, and this was increased further with OAG stimulation. The majority of detectable Ca2+ spark activity was blocked by dnTRPC6, even in the presence of OAG. TRPC3- or TRPC6-mediated Ca2+ spark activity was also significantly inhibited by the Ca2+/calmodulin protein kinase II (CaMKII) inhibitor KN93, suggesting that this process may in part result from local activation of CaMKII and phosphorylation of RyR2. To address this issue, we measured phosphorylation of RyR at S2814, which is a CaMKII phosphorylation site, in AFMs infected with TRPC3±dnTRPC6 and ±OAG (Figure 4A–4C) or TRPC6±dnTRPC4 and ±OAG (Online Figure IV). These experiments show that TRPC3 and TRPC6 induce RyR S2814 and phospholamban T17 phosphorylation (Figure 4C and 4F) without modifying RyR S2808 or phospholamban S16 phosphorylation (Figure 4B and 4E) or total RyR or phospholamban expression (Figure 4D and 4G). OAG-mediated increases in RyR S2814 and phospholamban T17 phosphorylation was reduced by CaMKII inhibition (KN93; Figure 4C and 4F; Online Figure IV). We also found that TRPC3 or TRPC6 expression in AFMs was associated with diminished contractile response to catecholamines as evidenced by a reduction in maximal amplitude of fractional shortening and peak Ca2+ transients in the presence of isoproterenol (Figure 3C and 3D).
Transient receptor potential canonical (TRPC) channels induce sarcoplasmic reticulum Ca2+ leak and spark activity in adult feline myocytes (AFMs) and lead to a reduction in contractility reserve. A, Representative serial confocal images taken to detect spontaneous Ca2+ spark events in AFMs infected with the indicated adenoviruses at baseline or with OAG treatment. Scale bar is 5 μm. Fluorescence intensity of Fluo-4 signal is indicated in a scale of arbitrary units (f.a.u.). KN93 was used at 10 umol/L. B, Spark events were quantified and average data of n=20 cells (ns, P>0.05; ***P≤0.001 vs red fluorescent protein [RFP] control; #P≤0.05, ##P≤0.01 vs TRPC3, &P≤0.05, &&P≤0.01 vs TRPC6). C, Average fractional shortening data and peak Ca2+ transients (D) from AFMs infected with the indicated adenovirus at baseline and after exposure to isoproterenol (Iso). P<0.05 was considered significant with *P≤0.05 vs RFP control; #P≤0.05 or ##P≤0.01 vs baseline of same experimental group.
Transient receptor potential canonical (TRPC) channels induce Ca2+/calmodulin protein kinase II–mediated ryanodine receptor 2 (RyR2) and phospholamban (PLN) phosphorylation. Whole-cell lysates from adult feline myocytes infected with Ad-RFP, -TRPC3, -dnTRPC6, or -TRPC3 and -dnTRPC6 at baseline or treated with OAG (10 umol/L) were analyzed by Western blot with the indicated antibodies. KN93 (10 umol/L) was used in addition to OAG where noted. A representative Western blot is shown in A. B to G, Average quantified values expressed relative to Ad-RFP control cells at baseline for n=3 experiments. P<0.05 was considered significant (ns, P>0.05, *P≤0.05, **P≤0.01).
TRPC Channels Localize to Caveolae Where Their Organization Is Essential for Hypertrophic Signaling
Previous work from our group showed that Ca2+ influx through both TRPCs and LTCC contributes to the activation of Cn-NFAT signaling and indicated that there may be a potential interaction between the channels.22 This interaction might take place within subcellular signaling microdomains such as caveolae,25 and it is known that nearly all TRPC isoforms contain a putative caveolin-binding motif.43 To explore this further, we characterized the biochemical interactions between TRPCs, LTCC, and caveolin-3, the major structural protein of myocyte caveolae, using immunoprecipitation with purified plasma membranes from isolated ventricular myocytes of dnTRPC4 transgenic mice (Figure 5A) or AFMs infected with a FLAG-tagged version of TRPC6 (Ad-TRPC6-FLAG; Online Figure VA). Our immunoprecipitation data show that caveolin-3, LTCC, and TRPC channels are all complexed together in caveolae. This was further substantiated using sucrose density gradient fractionation of plasma membrane preparations from AFMs infected with Ad-TRPC3 (Figure 5B).
Transient receptor potential canonical (TRPC) channels colocalize with l-type Ca2+ channel (LTCC) in caveolae membrane microdomains where their organization is required for hypertrophic signaling. A, Plasma membranes (PMs) were purified from total cell homogenates (H) of isolated myocytes from dominant-negative TRPC4 mice. Immunoprecipitations (IPs) and Westerns were performed with the indicated antibodies (B indicates bound fraction; and U, unbound fraction). B, Sucrose density gradient fractionation on purified PMs from isolated adult feline myocytes (AFMs) infected with Ad-TRPC3 confirms the presence of LTCC and TRPC3 channels in caveolin-3 (Cav3)–enriched lipid raft membrane fractions along with the hypertrophic effector calcineurin (Cn; fraction 1 to fraction 11, F1–F11). C, AFMs were infected with Ad-NFAT-GFP and the indicated adenoviruses and NFAT translocation was monitored in response to the TRPC agonist OAG (10 umol/L) in the presence or absence of methyl-β-cyclodextrin (MβCD; 10 mmol/L). Scale bar is 10 μm. Average data are represented in D as the nuclear to cytoplasmic GFP ratio of n=100 cells per condition. P<0.05 was considered significant with *P≤0.05; **P≤0.001; ***P≤0.001 vs red fluorescent protein control; ##P≤0.001; ###P≤0.001 vs TRPC3; &&P≤0.001; &&&P≤0.001 vs TRPC6.
To examine the functional relevance of TRPC channels localized to caveolae, we assessed their role in pathological hypertrophic signaling using an NFAT-GFP reporter assay.25,44 AFMs were infected with Ad-NFAT-GFP and either Ad-RFP (control), -TRPC3, -TRPC4, -TRPC6, -TRPC3 and -dnTRPC6, or -TRPC6 and -dnTRPC4. Essentially all of the NFAT-GFP was localized to the cytoplasm in control AFMs (Figure 5C and 5D). Ad-TRPC3, -TRPC4, and -TRPC6–infected cells showed a small but significant increase in baseline nuclear NFAT signal, which was inhibited by coinfection with dnTRPC6 or dnTRPC4 (Figure 5C and 5D; Online Figure VI). Exposing myocytes to OAG caused a very slight increase in NFAT translocation in control cells and a significant increase in nuclear NFAT in TRPC3- or TRPC6-infected cells (Figure 5C and 5D). Incubating TRPC4-infected cells with high Ca2+ (4 mmol/L) also led to a significant increase in NFAT translocation (Online Figure VIC). The TRPC3/4/6 effect was eliminated with coinfection with dnTRPC6 or dnTRPC4 (Figure 5C and 5D). To further assess whether organizing Ca2+ influx pathways in caveolae is essential for NFAT regulation, we subjected myocytes to treatment with methyl-β-cyclodextrin, which disrupts caveolae by depleting cholesterol and displaces the macromolecular signaling complexes usually organized in caveolae microdomains (Online Figure V). Methyl-β-cyclodextrin inhibited TRPC3/4/6-mediated NFAT nuclear translocation in the presence of OAG or high Ca2+ (Figure 5C and 5D; Online Figure VI), suggesting that the organization of LTCC and TRPC channels together in caveolae signaling microdomains is necessary for them to activate hypertrophic signaling.
A previous study from our group characterized a caveolae-targeted LTCC inhibitor, Rem1-265-Cav, which could specifically inhibit LTCC with caveolin-3 microdomains, to reduce NFAT nuclear translocation without affecting contractility.25 When we coinfected NFAT-GFP–expressing AFMs with Ad-TRPC3 and -Rem1-265-Cav and treated these cells with OAG, we saw a significant inhibition of NFAT translocation (Figure 5C and 5D). These results suggest that TRPC channels and LTCC housed together in caveolae membrane microdomains provide a source of Ca2+ that induces calcineurin activation and nuclear NFAT translocation.
TRPCs are relatively nonselective cation channels that allow both Na+ and Ca2+ entry. Others have shown that Na+ entry through the Na+/H+ exchanger (NHE-1) increases local Ca2+ via NCX, leading to NFAT activation.45,46 Using both caveolin-3 immunoisolations and sucrose density gradients, we found the presence of both NHE-1 and NCX in caveolae membrane microdomains (Online Figure VII). To look specifically at a functional role for NHE-1 in our model, we performed NFAT-GFP assay in TRPC3/4/6 in the presence of the NHE-1 inhibitor cariporide (Online Figure VID) and found that there was no effect on NFAT translocation in these cells. These data suggest that although NHE-1 colocalizes with TRPC, it is not contributing to TRPC-mediated NFAT activation under our conditions.
Loss of TRPC Function Protects Against Cardiac Dysfunction Progression After MI and Improves Survival
After MI, myocytes develop pathological hypertrophy, myocyte function is altered, and TRPC channel expression increases. Overexpression of TRPC channels in the mouse heart is sufficient to induce hypertrophy and cardiomyopathy,5,7,20 and mice expressing dominant-negative versions of the channel have less hypertrophy in response to pressure overload or neuroendocrine agonist infusion.8,21 Taken together with our in vitro findings, these data support the idea that inhibiting TRPC function in the heart could be beneficial after MI. To test this idea, we used a transgenic mouse with cardiac-specific expression of a truncated dnTRPC421 that reduces the activity of both the TRPC1/4/5 and TRPC3/6/7 subfamilies of TRPC channels.21 TRPC mRNA levels were not significantly different between wild-type (WT) and dnTRPC4 mice both in sham and MI groups (Figure 6; Online Figure VIII) with the exception of TRPC4, which was markedly increased in dnTRPC4 animals because of overexpression of the transgene. TRPC-mediated Ca2+ entry seen in WT 6-week MI myocytes, which could be partially inhibited by the selective TRPC3/6 antagonist GSK503A or the TRPC3 inhibitors Pyr3 or Pyr10 or completely inhibited with SKF-96365, was not present in dnTRPC4 mice (Figure 6). Echocardiography measurements revealed a slightly increased baseline ejection fraction in dnTRPC4 mice compared with WT animals (75.5% versus 68.2%; Figure 7A and 7B), consistent with the inotropic effects of dnTRPC6 observed in AFMs. The area at risk after MI was identical in WT and dnTRPC4 mice (41.3±3.8% versus 43.5±4.9%; Online Figure IIIA). Infarct length measured 3 weeks after MI was not significantly different in dnTRPC4 than in WT mice (dnTRPC4 versus WT: 28.7±1.7% versus 33.2±0.9%; Online Figure IXB). In addition, the dilation seen in WT mice 3 weeks post-MI was attenuated in dnTRPC4 hearts (Online Figure IXC andn IXD).
Transient receptor potential canonical (TRPC) channel expression and activity in wild-type (WT) and dominant-negative (dn) TRPC4 transgenic (TG) mice. A, Reverse transcriptase polymerase chain reaction shows an upregulation of TRPC1/3/4/6 channel isoforms 6 wk post–myocardial infarction (MI) along with the activation of the fetal gene program compared with sham animals. dnTRPC4 TG myocytes show similar levels of baseline TRPC expression levels and TRPC1/3/6 upregulation post-MI but show reduced atrial natriuretic factor (ANF) and skeletal muscle actin (SMA) compared with WT mice post-MI. B, TRPC-mediated Ca2+ entry in isolated myocytes from sham mice (left) and dnTRPC4 TG mice (right) post-MI in the presence of the TRPC channel agonist OAG (10 umol/L) and the sarcoplasmic reticulum Ca2+ ATPase inhibitor cyclopiazonic acid (5 umol/L). Where indicated, the TRPC antagonists SKF-96365 (5 umol/L), GSK503A (GSK; 10 umol/L), Pyr3 (3 umol/L), Pyr10 (3 umol/L) or the l-type Ca2+ channel inhibitor nifedipine (Nif; 10 umol/L) were used. P<0.05 was considered significant (ns, P>0.05; *P≤0.05, **P≤0.01, ***P≤0.001 vs WT sham; #P≤0.05, ##P≤0.01; ###P≤0.001 vs dnTRPC4 sham; &P≤0.05 vs WT 6 wk MI). BNP indicates brain natriuretic peptide; and MHC, myosin heavy chain.
Cardiac function and survival was improved and pathological remodeling attenuated in dominant-negative transient receptor potential canonical isoform 4 (dnTRPC4) mice vs wild-type (WT) animals post–myocardial infarction (MI). A, Representative M-mode tracings from sham and MI animals at 6 wk post-MI. Average cardiac ejection fraction (B), posterior wall thickness (C), and left ventricular (LV) internal diameter (D) were measured by echocardiography in sham and MI mice at baseline and 2 and 6 wk post-MI. E, Six-week survival data analyzed using a Kaplan–Meier regression of WT vs dnTRPC4 mice. Significance was determined using the log-rank test. Heart weight (HW; F) or lung weight (LungW; G) normalized to body weight (BW) measured in sham and MI mice after 6 wks. P<0.05 was considered significant (ns, P>0.05, *P≤0.05, **P≤0.01, ***P≤0.001).
Serial echocardiography was used to measure left ventricular structure and function after MI. WT (ejection fraction: sham versus MI, 68.2% versus 37.2%) and dnTRPC4 (ejection fraction: sham versus MI, 75.5% versus 41.8%) animals had equivalent reductions in cardiac pump function 2 weeks after MI (Figure 7B). Left ventricular function remained depressed at 6 weeks post-MI in WT animals, whereas there was a significant improvement in cardiac pump function in dnTRPC4 hearts 6 weeks after MI (Figure 7A and 7B).
There were significant pathological changes in ventricular geometry and wall thickness in all hearts after MI (Figure 7C and 7D). The magnitude of these changes increased with time in WT animals but was attenuated in dnTRPC4 mice. After MI, posterior wall thickness was decreased in both WT and dnTRPC4 hearts (WT pre-MI versus post-MI: 0.97 versus 0.87 mm; dnTRPC4: 1.06 versus 0.84 mm; Figure 7C). At 6 weeks post-MI, posterior wall thickness returned to values near pre-MI levels (or close to shams) in dnTRPC4 hearts, whereas posterior wall thickness remained thinner in WT hearts. All hearts showed some evidence of dilation after MI; however, left ventricular internal diameter increased significantly more in WT than in dnTRPC4 hearts in the first 2 weeks after MI (WT pre-MI versus post-MI: 3.8 versus 4.9 mm; dnTRPC4: 3.7 versus 4.5 mm; Figure 7D). By 6 weeks post-MI, left ventricular internal diameter was significantly more dilated in WT hearts than in dnTRPC4 (WT versus dnTRPC4: 5.3 versus 4.8 mm).
dnTRPC4 mice had significantly greater survival after MI (53.7%) than WT animals (27.5%) during the 6-week post-MI study period (Figure 7E). Heart weight/body weight and lung weight/body weight were significantly increased (Figure 7F and 7G) in WT versus dnTRPC4 mice 6 weeks post-MI. There were minimal changes in liver weight/body weight ratio before and after MI, and there was no significant difference between dnTRPC4 and WT mice (Online Figure IXE). Dephosphorylation of NFAT induces cytoplasmic to nuclear translocation. Six-week MI dnTRPC4 mice had increased levels of phosphorylated NFAT as compared with WT 6-week MI mice, indicating reduced NFAT dephosphorylation in dnTRPC4 mice (Online Figure XA–XC). In accordance with this, isolated myocytes from 2- and 6-week post-MI WT had significantly greater length and width than in dnTRPC4 mice (Online Figure XD and XE). Collectively, these results show that dnTRPC4 animals have less pathological remodeling after MI, improved cardiac pump function, and enhanced survival.
Myocytes From dnTRPC4 Mice Retain Their Hypercontractile Phenotype After MI
One potential mechanism for improved cardiac function after MI in dnTRPC4 versus WT hearts is that myocyte function and adrenergic responsiveness are better preserved. To address this idea, we first measured twitch contractions and [Ca]2+i transients in the absence and presence of isoproterenol in dnTRPC4 and WT myocytes after sham or MI procedures. Representative data are shown in Online Figure XIA and XIB. Fractional shortening of dnTRPC4 was significantly greater than in WT (sham) myocytes (dnTRPC4 versus WT: 11.0±0.6% versus 8.4±0.6%; Figure 8A). After MI, contractions remained significantly greater in dnTRPC4 than in WT myocytes (dnTRPC4 versus WT: 13.4±1.1% versus 8.9±0.4%).
Fractional shortening (FS), Ca2+ transients, and l-type Ca2+ current (ICa,L) measured in isolated cardiac myocytes from sham and post–myocardial infarction (MI) hearts. Cellular FS, Ca2+ transients, and ICa,L were measured in myocytes isolated from sham and 3-wk post-MI wild-type and dominant-negative transient receptor potential canonical isoform 4 mice in the presence and absence of isoproterenol (Iso). Average data are shown for FS (A), peak Ca2+ transients (B), FS half width (C), Ca2+ decay rate (Tau; D), peak ICa,L (E), and membrane capacitance (F). P<0.05 was considered significant (ns, P>0.05, *P≤0.05, **P≤0.01)
Myocyte contractions in both WT and dnTRPC4 cells increased with isoproterenol (WT sham±isoproterenol: 8.4±0.6% versus 11.7±0.8%; dnTRPC4 sham±isoproterenol: 11.0±0.6% versus 13.5±0.6%) with baseline contractions in dnTRPC4 being greater than in WT (Figure 8A). Post-MI, dnTRPC4 myocytes again had greater baseline contractions and isoproterenol response than WT myocytes (post-MI WT±isoproterenol: 8.9±0.4% versus 13.0±0.4%; post-MI dnTRPC4±isoproterenol: 13.4±1.1% versus 16.0±0.8%).
Peak systolic [Ca]2+i in dnTRPC4 (sham) myocytes was significantly greater than in WT myocytes (Figure 8B), explaining their greater twitch contractions. After MI, [Ca]2+i transients in dnTRPC4 myocytes remained significantly greater than in WT myocytes (peak F/F0 in dnTRPC4 sham versus WT sham: 3.0±0.3 versus 2.1±0.3; post-MI dnTRPC4 versus WT: 3.6±0.5 versus 2.5±0.2). Isoproterenol significantly increased Ca2+ transient amplitude in both WT and dnTRPC4 myocytes, with Ca2+ transient amplitude being significantly greater in dnTRPC4 myocytes (WT [sham]±isoproterenol: 2.1±0.3 versus 3.5±0.4; dnTRPC4 [sham]±isoproterenol: 3.0±0.3 versus 4.4±0.5; post-MI WT±isoproterenol: 2.5±0.2 versus 3.6±0.6; post-MI dnTRPC4±isoproterenol: 3.6±0.5 versus 6.0±0.8; Figure 8B).
Contraction half width and the time constant of decay (Tau) of [Ca]2+i transients were also measured. Half width (±isoproterenol conditions) was significantly less in dnTRPC4 (sham) versus WT (sham) myocytes (dnTRPC4 [sham]±isoproterenol: 220±11 versus 209±9 ms; WT [sham]±isoproterenol: 280±20 versus 261±17 ms; Figure 8C). MI induced changes (half width increase) in the duration of contractions in both dnTRPC4 and WT myocytes. After MI, half width of contractions (±isoproterenol conditions) remained significantly less in dnTRPC4 versus WT myocytes (dnTRPC4 [MI]±isoproterenol: 247±16 versus 230±14 ms; WT [MI]±isoproterenol: 315±15 versus 279±11 ms; Figure 8C). Isoproterenol induced significant decreases in Tau in both WT and dnTRPC4 myocytes after sham or MI (Figure 8D). There were no significant differences in Tau between WT and dnTRPC4 myocytes after sham or MI±isoproterenol conditions (Figure 8D). Collectively, these data show that myocytes from dnTRPC4 MI hearts retain a hypercontractile phenotype after MI.
LTCC Current (ICa,L) Was Not Different Between dnTRPC4 and WT Myocytes After Sham or MI
Altered function of LTCC and loss of adrenergic regulation is a common feature of diseased cardiac myocytes.47 We next examined if loss of TRPC function influenced the behavior of LTCC either before or after MI. LTCC currents were measured in single isolated myocytes from WT and dnTRPC4 hearts with or without MI. ICa,L density was not significantly different in sham dnTRPC4 versus WT myocytes (peak ICa,L in dnTRPC4 versus WT: −13.0±1.4 versus −12.1±0.85 pA/pF; Figure 8E). Isoproterenol increased ICa,L density in both sham dnTRPC4 myocytes (pre-isoproterenol versus after isoproterenol: −13.0±1.4 versus −22.5±2.8 pA/pF) and sham WT myocytes (−12.1±0.85 to −20.9±1.9 pA/pF). After MI, ICa,L density was decreased to a similar extent in all myocytes (dnTRPC4 versus WT: −11.8±1.7 versus −10.4±1.1 pA/pF; Figure 8E). However, only dnTRPC4 myocytes showed a significant increase in ICa,L with isoproterenol after MI (pre-isoproterenol versus after isoproterenol: −11.8±1.7 versus −18.3±2.5 pA/pF). Cell capacitance (Figure 8F) and cell size (Online Figure XD and XE) were similar in sham WT and dnTRPC4 animals, but a significant increase in cell capacitance was seen in WT cells after MI (Figure 8F) but not in dnTRPC4 myocytes.
Discussion
This study explored the idea that Ca2+ influx through TRPC channels expressed after MI contributes to altered myocyte contractility and hypertrophic signaling. Our studies revealed a low level of TRPC isoform expression in normal adult mouse and AFMs, with a significant increase in select TRPC isoform expression after MI (Figure 1). TRPC was shown to induce SOCE, which was abolished with a dnTRPC6-expressing adenovirus. Using AFMs, we showed that Ca2+ entry through TRPC3 could load the SR when SR Ca2+ stores were naturally depleted but could overload the SR and cause spontaneous SR Ca2+ release (Ca2+ sparks, leak) if SOCE was persistent or excessive, and these effects seem to be because of CaMKII-mediated RyR S2814 phosphorylation (Figure 4). TRPC expression was associated with reduced contractile effects of catecholamines. Our studies also showed that a fraction of TRPC channels is localized to caveolae, where together with LTCCs they activate pathological hypertrophic signaling. Finally, mice with cardiac myocyte−specific expression of dnTRPC4 had less cardiac dysfunction and adverse remodeling after MI.
TRPC Expression in Disease
A clear link between Ca2+ influx and cardiac hypertrophy has been established,1,48 and activation of Cn-NFAT signaling is known to initiate the coordinated expression of maladaptive hypertrophic genes, and overstimulation of this pathway can lead to heart failure.3,49,50 Multiple in vitro5,22,24,51,52 and in vivo7,20,21,51,53 TRPC expression systems have documented a role for these channels in the induction of Cn-NFAT signaling and subsequent hypertrophic remodeling. TRPC loss-of-function6,8,21,24,54 and selective inhibition23,24,53 animal models are protected against cardiac hypertrophy and indices of heart failure after either pressure overload or neurohormonal stress. In accordance with these studies, we found that cardiac-specific overexpression of dnTRPC4 resulted in reduced pathological remodeling in an MI model of injury (Figure 7) and a cardioprotective phenotype that increased survival post-MI.
TRPC, SOCE, and Myocyte Contractility
Progressive deterioration of cardiac contractility is a central feature of heart failure, and alterations of intracellular Ca2+ regulation are primarily responsible for this depression in contractility reserve.1,47 In this study, we explored the hypothesis that TRPC channels expressed in diseased myocytes contribute to their deteriorating contractility. Others have found that cardiac-specific overexpression of TRPC6 in mice resulted in an exaggerated hypertrophic response to pressure overload with decreased systolic function,7 and a similar study showed that TRPC3 transgenic mice developed a loss of ventricular performance with profound cardiomyopathy.20 We found enhanced cardiac pump function in cardiac-specific dnTRPC4 mice (Figure 7A and 7B) and increased myocyte fractional shortening and peak Ca2+ transients (Figure 8A and 8B). These are somewhat curious findings, because TRPC is a pathway for Ca2+ influx, and this would be expected to increase rather than decrease contractile Ca2+. To examine if/how TRPC channels cause alterations in myocyte contractility, TRPC3, TRPC4, TRPC6 or dnTRPC6 and dnTRPC4 were expressed in AFMs. We found that the changes in AFM contractile function were dependent on the experimental conditions. When normal or RFP-infected AFMs were unpaced for a period of time, their SR Ca2+ stores became depleted (Figure 2A–2C). TRPC3/4/6 expression resulted in enhanced rested-state contractions (Figure 2A–2C), suggesting that when SR Ca2+ stores are depleted, TRPC channels can supply Ca2+ for refilling. However, in paced AFMs, TRPC3/6 resulted in reduced steady-state contractile function and reduced responsiveness to catecholamines (Figure 3C). TRPC3/6 overexpression induced Ca2+ sparks (Figure 3A and 3B), suggesting that altered contractility was because of enhanced SR Ca2+ leak. Finally, we showed that increased TRPC3/6 activity was associated with RyR S2814 phosphorylation that was reduced by CaMKII inhibition (Figure 4A and 4C). These results suggest that although Ca2+ influx through TRPC channels can replenish depleted SR Ca2+ stores, excess TRPC channel activity causes local activation of CaMKII and phosphorylation of RyR at S2814, resulting in abnormal RyR function, producing spontaneous diastolic SR Ca2+ release leading to depressed contractility reserve.
TRPC and Hypertrophy Signaling
Many groups have shown that TRPC channels contribute to the activation of Cn-NFAT signaling and hypertrophic response.6,21,22,55 Data from our study are in accordance with this and expand on what is known to show that the organization of TRPC channels along with LTCC in caveolae membrane microdomains influences their ability to orchestrate Cn-NFAT signaling. TRPC channels are known to allow influx of both Na+ and Ca2+, and it has been shown by others that Na+ entry via NHE-1 and induce Ca2+ entry via the NCX to activate NFAT activation.45,46,56 We found both NHE-1 and NCX in caveolae membrane microdomains (Online Figure VII), suggesting that they could contribute to TRPC-mediated NFAT activation in these signaling microdomains. We addressed this by inhibiting NHE-1 with cariporide (Online Figure VID) but saw no change in TRPC-mediated NFAT nuclear translocation, indicating that NHE-1 is not playing a central role in this process in our system. However, our experimental design is unable to definitively rule out a role for Na+ in this process, and it is possible that TRPC-mediated Na+ entry is also a contributing factor to Cn-NFAT.
TRPC Inhibition Post-MI
Finally, an in-depth characterization of an MI model of injury in dnTRPC4 transgenic mice was used to determine if reducing TRPC channel activity after MI reduced structural and functional remodeling and had a beneficial outcome. We found that dnTRPC4 mice did not exhibit TRPC-mediated Ca2+ entry after MI and had less pathological hypertrophy, better cardiac performance, less progression of heart failure, and increased survival after MI compared with WT animals (Figures 6 and 7; Online Figures IX and X).
Collectively, our studies show that TRPC channels are stress-response molecules that are upregulated in chronic cardiac disease states. Mechanistically, our data suggest that TRPC channels disrupt normal SR Ca2+ storage by inducing SR Ca2+ leak to contribute to depressed contractility reserve in disease. These effects are accompanied by coordinated Ca2+-activated Cn-NFAT signaling through caveolae membrane microdomains. These data suggest that targeted inhibition of cardiac myocyte TRPC channels might be an effective strategy for attenuating pathological structural remodeling and for maintaining contractility reserve after MI.
Sources of Funding
This work was supported by National Institutes of Health grants to S.R. Houser and J.D. Molkentin and an American Heart Association predoctoral fellowship to C.A. Makarewich.
Disclosures
None.
Footnotes
In June 2014, the average time from submission to first decision for all original research papers submitted to Circulation Research was 15 days.
The online-only Data Supplement is available with this article at http://circres.ahajournals.org/lookup/suppl/doi:10.1161/CIRCRESAHA.115.303831/-/DC1.
- Nonstandard Abbreviations and Acronyms
- AFM
- adult feline myocyte
- CaMKII
- Ca2+/calmodulin protein kinase II
- Cn-NFAT
- calcineurin-nuclear factor of activated T cells
- dn
- dominant-negative
- LTCC
- l-type Ca2+ channel
- MI
- myocardial infarction
- NCX
- Na+/Ca2+ exchanger
- NHE-1
- Na+/H+ exchanger
- OAG
- 1-oleoyl-2-acetyl-sn-glycerol
- RFP
- red fluorescent protein
- RyR
- ryanodine receptor
- SOCE
- store-operated Ca2+ entry
- SR
- sarcoplasmic reticulum
- TRPC
- transient receptor potential canonical
- WT
- wild type
- Received February 26, 2014.
- Revision received July 17, 2014.
- Accepted July 21, 2014.
- © 2014 American Heart Association, Inc.
References
- 1.↵
- 2.↵
- Pfeffer MA,
- Braunwald E
- 3.↵
- 4.↵
- 5.↵
- Bush EW,
- Hood DB,
- Papst PJ,
- Chapo JA,
- Minobe W,
- Bristow MR,
- Olson EN,
- McKinsey TA
- 6.↵
- Eder P,
- Molkentin JD
- 7.↵
- 8.↵
- Seth M,
- Zhang ZS,
- Mao L,
- Graham V,
- Burch J,
- Stiber J,
- Tsiokas L,
- Winn M,
- Abramowitz J,
- Rockman HA,
- Birnbaumer L,
- Rosenberg P
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- Nilius B,
- Owsianik G,
- Voets T,
- Peters JA
- 13.↵
- Abramowitz J,
- Birnbaumer L
- 14.↵
- Seo K,
- Rainer PP,
- Lee DI,
- Hao S,
- Bedja D,
- Birnbaumer L,
- Cingolani OH,
- Kass DA
- 15.↵
- Hofmann T,
- Schaefer M,
- Schultz G,
- Gudermann T
- 16.↵
- Poteser M,
- Graziani A,
- Rosker C,
- Eder P,
- Derler I,
- Kahr H,
- Zhu MX,
- Romanin C,
- Groschner K
- 17.↵
- Alessandri-Haber N,
- Dina OA,
- Chen X,
- Levine JD
- 18.↵
- Kobori T,
- Smith GD,
- Sandford R,
- Edwardson JM
- 19.↵
- 20.↵
- Nakayama H,
- Wilkin BJ,
- Bodi I,
- Molkentin JD
- 21.↵
- Wu X,
- Eder P,
- Chang B,
- Molkentin JD
- 22.↵
- 23.↵
- Kiyonaka S,
- Kato K,
- Nishida M,
- et al
- 24.↵
- Seo K,
- Rainer PP,
- Shalkey Hahn V,
- Lee DI,
- Jo SH,
- Andersen A,
- Liu T,
- Xu X,
- Willette RN,
- Lepore JJ,
- Marino JP Jr.,
- Birnbaumer L,
- Schnackenberg CG,
- Kass DA
- 25.↵
- Makarewich CA,
- Correll RN,
- Gao H,
- Zhang H,
- Yang B,
- Berretta RM,
- Rizzo V,
- Molkentin JD,
- Houser SR
- 26.↵
- duBell WH,
- Houser SR
- 27.↵
- Duthinh V,
- Houser SR
- 28.↵
- Jaleel N,
- Nakayama H,
- Chen X,
- Kubo H,
- MacDonnell S,
- Zhang H,
- Berretta R,
- Robbins J,
- Cribbs L,
- Molkentin JD,
- Houser SR
- 29.↵
- Zhang H,
- Chen X,
- Gao E,
- et al
- 30.↵
- Zhang H,
- Makarewich CA,
- Kubo H,
- Wang W,
- Duran JM,
- Li Y,
- Berretta RM,
- Koch WJ,
- Chen X,
- Gao E,
- Valdivia HH,
- Houser SR
- 31.↵
- 32.↵
- 33.↵
- 34.↵
- 35.↵
- 36.↵
- Silver LH,
- Hemwall EL,
- Marino TA,
- Houser SR
- 37.↵
- Schleifer H,
- Doleschal B,
- Lichtenegger M,
- Oppenrieder R,
- Derler I,
- Frischauf I,
- Glasnov TN,
- Kappe CO,
- Romanin C,
- Groschner K
- 38.↵
- Koch-Weser J,
- Blinks JR
- 39.↵
- Bers DM
- 40.↵
- Cheng H,
- Lederer WJ,
- Cannell MB
- 41.↵
- Cheng H,
- Lederer WJ
- 42.↵
- Pieske B,
- Houser SR,
- Hasenfuss G,
- Bers DM
- 43.↵
- Cohen AW,
- Hnasko R,
- Schubert W,
- Lisanti MP
- 44.↵
- 45.↵
- 46.↵
- Nakamura TY,
- Iwata Y,
- Arai Y,
- Komamura K,
- Wakabayashi S
- 47.↵
- Houser SR,
- Margulies KB
- 48.↵
- 49.↵
- De Windt LJ,
- Lim HW,
- Taigen T,
- Wencker D,
- Condorelli G,
- Dorn GW II.,
- Kitsis RN,
- Molkentin JD
- 50.↵
- Olson EN,
- Molkentin JD
- 51.↵
- Kinoshita H,
- Kuwahara K,
- Nishida M,
- et al
- 52.↵
- Onohara N,
- Nishida M,
- Inoue R,
- Kobayashi H,
- Sumimoto H,
- Sato Y,
- Mori Y,
- Nagao T,
- Kurose H
- 53.↵
- 54.↵
- Luo W,
- Grupp IL,
- Harrer J,
- Ponniah S,
- Grupp G,
- Duffy JJ,
- Doetschman T,
- Kranias EG
- 55.↵
- Poteser M,
- Schleifer H,
- Lichtenegger M,
- Schernthaner M,
- Stockner T,
- Kappe CO,
- Glasnov TN,
- Romanin C,
- Groschner K
- 56.↵
Novelty and Significance
What Is Known?
Transient receptor potential canonical (TRPC) channels are present in low abundance in the normal heart, and their expression is increased by pressure overload.
TRPC channels contribute to cardiac hypertrophy and disease progression in pressure overload.
What New Information Does This Article Contribute?
TRPC channel expression increases after myocardial infarction (MI) and is associated with pathological remodeling and contractility reserve defects; inhibition of TRPC channels post-MI increased survival, reduced pathological remodeling, and improved cardiac function.
Ca2+ influx through TRPC channels activates Ca2+/calmodulin protein kinase II resulting in Ca2+ leak from sarcoplasmic reticulum stores and reduces contractility reserve.
TRPC channels organized in caveolae membrane signaling microdomains provide a local Ca2+ signal that activates calcineurin-nuclear factor of activated T-cells signaling, a well-established upstream mediator of pathological hypertrophy.
TRPC channel expression and activity is increased in models of pathological hypertrophy and heart failure. We asked if and how Ca2+ influx through TRPC channels contributes to the structural remodeling and contractility defects seen after MI. We found that isoforms of the TRPC channel were upregulated after MI. The biological activity of TRPC channels was linked to reduced sarcoplasmic reticulum Ca2+ stores using an in vitro system. Our studies showed that TRPC activity triggered spontaneous sarcoplasmic reticulum Ca2+ release that was linked to Ca2+/calmodulin protein kinase II activation and downstream modification of ryanodine receptors making them more prone to leak. These changes resulted in a reduction of contractility reserve. Our results showed that TRPC channels localized to caveolae membrane domains are involved in stress-mediated activation of calcineurin-nuclear factor of activated T-cells signaling. TRPC channel inhibition with a cardiac-specific dominant-negative TRPC construct reduced pathological structural and functional remodeling after MI and improved survival. These studies suggest that after MI, the biological activity of TRPC channels perpetuates cardiac hypertrophy and contributes to depression of contractility reserve.
This Issue
Jump to
Article Tools
- Transient Receptor Potential Channels Contribute to Pathological Structural and Functional Remodeling After Myocardial InfarctionNovelty and SignificanceCatherine A. Makarewich, Hongyu Zhang, Jennifer Davis, Robert N. Correll, Danielle M. Trappanese, Nicholas E. Hoffman, Constantine D. Troupes, Remus M. Berretta, Hajime Kubo, Muniswamy Madesh, Xiongwen Chen, Erhe Gao, Jeffery D. Molkentin and Steven R. HouserCirculation Research. 2014;115:567-580, originally published July 21, 2014https://doi.org/10.1161/CIRCRESAHA.115.303831
Citation Manager Formats
Share this Article
- Transient Receptor Potential Channels Contribute to Pathological Structural and Functional Remodeling After Myocardial InfarctionNovelty and SignificanceCatherine A. Makarewich, Hongyu Zhang, Jennifer Davis, Robert N. Correll, Danielle M. Trappanese, Nicholas E. Hoffman, Constantine D. Troupes, Remus M. Berretta, Hajime Kubo, Muniswamy Madesh, Xiongwen Chen, Erhe Gao, Jeffery D. Molkentin and Steven R. HouserCirculation Research. 2014;115:567-580, originally published July 21, 2014https://doi.org/10.1161/CIRCRESAHA.115.303831